DABIGATRAN ETEXILATO LICONSA 150 MG CAPSULAS DURAS EFG

Laboratorios Liconsa S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a329786afc06675a
Drug Cima Aemps Name: DABIGATRAN ETEXILATO LICONSA 150 MG CAPSULAS DURAS EFG
Register Number: 89912
Holder Company Name: Laboratorios Liconsa S.A.
Marketing Company Name: Laboratorios Liconsa S.A.
Holder Company Detail Path: /organization/laboratorios-liconsa-sa
Marketing Company Detail Path: /organization/laboratorios-liconsa-sa
Authorization Date: 2024-11-05
Dosage Form: CÁPSULA DURA
Dose: 150 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Liconsa S.A.
Company Detail Path: /organization/laboratorios-liconsa-sa

DABIGATRAN ETEXILATO MESILATO

172,95 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 5, 2024

Approval ID

a329786afc06675a

Type

Standard